Tag:
S*BIO
Latest Headlines
Latest Headlines
S*Bio, Tragara forge $112M development pact
Singapore's S*BIO has inked a $112.5 million development deal for a multi-kinase inhibitor program. In S*BIO's second collaboration announced this month, San Diego-based Tragara Pharmaceuticals has
Onyx forges $550M pact for S*Bio programs
Singapore's S*Bio has inked a $550 million licensing deal with Onyx Pharmaceuticals covering the development and commercialization of its JAK2 inhibitors, SB1518 and SB1578. S*Bio gets $25 million of
S*BIO pockets $26M in second venture round
Singapore-based S*BIO has garnered $26 million in its second round of venture capital. That money will go to
